BioCryst Pharmaceuticals | BCRX - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Chugai Pharma JPY 14.46T 617.89B 2026-03
DBV Technologies USD 274M 17M 2025-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novavax USD 1.09B 316M 2025-12
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.28B 30M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03